Volume 61, Issue 6, Pages (June 2002)

Slides:



Advertisements
Similar presentations
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
A.M. Thompson, T.G. Pickering  Kidney International 
Plasma sodium and hypertension
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani 
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
Glomerulus number and blood pressure in the Prague hypertensive rat
Volume 53, Issue 4, Pages (April 1998)
Burden of chronic kidney disease: North Africa
Volume 65, Issue 6, Pages (June 2004)
Volume 57, Pages S32-S37 (April 2000)
Volume 79, Issue 12, Pages (June 2011)
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
Progression of diabetic nephropathy
Volume 54, Issue 4, Pages (October 1998)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 81, Issue 3, Pages (February 2012)
Volume 70, Issue 11, Pages (December 2006)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
Volume 71, Issue 11, Pages (June 2007)
Volume 56, Issue 3, Pages (September 1999)
Volume 87, Issue 2, Pages (February 2015)
Volume 91, Issue 5, Pages (May 2017)
Volume 74, Issue 9, Pages (November 2008)
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Elke Wühl, Otto Mehls, Franz Schaefer  Kidney International 
Volume 65, Issue 6, Pages (June 2004)
Blood pressure targets in hemodialysis patients
Volume 59, Issue 4, Pages (April 2001)
Fructose intake as a risk factor for kidney stone disease
Volume 62, Issue 3, Pages (September 2002)
Volume 87, Issue 1, Pages (January 2015)
Volume 67, Issue 1, Pages (January 2005)
The third World Kidney Day: Looking back and thinking forward
SYMPLICITY: not all that simple
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Methods for guideline development
Volume 87, Issue 1, Pages (January 2015)
The kidney, a cardiovascular risk marker, and a new target for therapy
Counteracting progression of renal disease: A look into the future
Nephrology Crossword: Glomerulonephritis
Citrate therapy for polycystic kidney disease in rats
Neurogenic factors and hypertension in renal disease
Circadian regulation of renal function
Volume 69, Issue 5, Pages (March 2006)
Volume 58, Issue 5, Pages (November 2000)
The course of the remnant kidney model in mice
Volume 53, Issue 6, Pages (June 1998)
This Month in AJKD American Journal of Kidney Diseases
Volume 55, Pages S3-S16 (June 1999)
Volume 63, Issue 6, Pages (June 2003)
Is it the low-protein diet or simply the salt restriction?
Is complement a target for therapy in renal disease?
Volume 68, Issue 1, Pages (July 2005)
Volume 58, Issue 3, Pages (September 2000)
Effect of prenatal dexamethasone on rat renal development
Patrick S. Parfrey, William S. Davidson, Jane S. Green 
Volume 61, Issue 1, Pages (January 2002)
Volume 55, Issue 3, Pages (March 1999)
Wendy E. Hoy, Megan Rees, Emma Kile, John D. Mathews, Zhiqiang Wang 
Familial phenotype differences in PKD11
Volume 65, Issue 2, Pages (February 2004)
Antonio Piccoli, Luana Pillon  Kidney International 
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Volume 61, Issue 6, Pages 2149-2156 (June 2002) Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat  Claude Braun, Thomas Kleemann, Ulrich Hilgenfeldt, Udo Riester, Peter Rohmeiss, Fokko J. Van Der Woude  Kidney International  Volume 61, Issue 6, Pages 2149-2156 (June 2002) DOI: 10.1046/j.1523-1755.2002.00385.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Effect of treatment with 2 mg/kg/day ramipril, 10 mg/kg/day HR 720, 2 × 200 μg SC HOE 140, or des-Arg9-BK for four days on systolic blood pressure in 3- and 9-month-old non-affected controls (SD) and polycystic kidney disease (PKD) rats (N = 10, each group). Symbols are: (□) 9-month-old PKD; (▵) 9-month-old SD; (○) 3-month-old PKD; (⋄) 3-month-old SD. Systolic blood pressure was significantly reduced in 9-month-old PKD and SD after treatment with ramipril and HR 720 (*P < 0.05). Data are presented as means ± SEM. Kidney International 2002 61, 2149-2156DOI: (10.1046/j.1523-1755.2002.00385.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Effects of treatment with 2 mg/kg/day ramipril, 10 mg/kg/day HR 720, 2 × 200 μg SC HOE 140, or des-Arg9-BK for four days on proteinuria in 3- and 9-month-old SD and PKD rats (N = 10, each group). Symbols are: (□) 9-month-old PKD; (▵) 9-month-old SD; (○) 3-month-old PKD; (⋄) 3-month-old SD. Proteinuria was significantly reduced in 3- and 9-month-old PKD after treatment with ramipril and HOE 140 (*P < 0.05). Data are presented as means ± SEM. Kidney International 2002 61, 2149-2156DOI: (10.1046/j.1523-1755.2002.00385.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Effect of treatment with 2 mg/kg/day ramipril, 10 mg/kg/day HR 720, 2 × 200 μg SC HOE 140, or des-Arg9-BK for four days on albuminuria in 3- and 9-month-old SD and PKD rats (N = 10, each group). Symbols are: (□) 9-month-old PKD; (▵) 9-month-old SD; (○) 3-month-old PKD; (⋄) 3-month-old SD. Albuminuria was significantly reduced in 3-and 9-month-old PKD after treatment with ramipril and HOE 140 (*P < 0.05). Data are presented as means ± SEM. Kidney International 2002 61, 2149-2156DOI: (10.1046/j.1523-1755.2002.00385.x) Copyright © 2002 International Society of Nephrology Terms and Conditions